4.8 Article

Mutations in TJP2 cause progressive cholestatic liver disease

Journal

NATURE GENETICS
Volume 46, Issue 4, Pages 326-+

Publisher

NATURE PUBLISHING GROUP
DOI: 10.1038/ng.2918

Keywords

-

Funding

  1. Alex Mowat PhD Studentship
  2. King's College Hospital Department of Research and Development
  3. National Institute for Health Research (NIHR) Biomedical Research Centre
  4. St Thomas' NHS Foundation Trust and King's College London
  5. Sir Jules Thorn Award for Biomedical Research [JTA/09]
  6. US National Institutes of Health (NIH) [R56 DK094828]
  7. University of California
  8. San Francisco (UCSF)-King's College Health Partners Faculty Fellowship Travel Grant (UCSF Academic Senate)
  9. US NIH [U01 DK062500, U01 DK062453, UL1 TR000154, U01 DK062456]
  10. National Human Genome Research Institute
  11. NHLBI [1U54HG006493]
  12. The Sir Jules Thorn Charitable Trust [09JTA] Funding Source: researchfish

Ask authors/readers for more resources

Elucidating genetic causes of cholestasis has proved to be important in understanding the physiology and pathophysiology of the liver. Here we show that protein-truncating mutations in the tight junction protein 2 gene (TJP2) cause failure of protein localization and disruption of tight-junction structure, leading to severe cholestatic liver disease. These findings contrast with those in the embryonic-lethal knockout mouse, highlighting differences in redundancy in junctional complexes between organs and species.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available